ALLK - アラコス (Allakos Inc.) アラコス

 ALLKのチャート


 ALLKの企業情報

symbol ALLK
会社名 Allakos Inc (アラコス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Allakos Inc. is a clinical-stage biotechnology company which is engaged in developing antibodies that selectively target mast cells and eosinophils. The Company's antibodies target receptor molecules present on the surface of immune effector cells which are involved in allergy inflammation and tissue damage. Its lead program is AK002 which is an antibody that targets Siglec-8 an inhibitory receptor found on eosinophils and mast cells. The Company's AK002 is used in the treatment of various diseases with abnormal proliferation of mast cells including eosinophilic gastritis (EG) indolent systemic mastocytosis urticaria and allergic conjunctivitis.   アラコスは米国のバイオ医薬品企業。臨床段階で、アレルギ―性疾患、炎症性疾患および増殖性疾患の治療用抗体の開発に従事する。同社は、好酸球性胃炎および胃腸炎、じんま疹、無症候性全身性肥満細胞症、重度のアレルギ―性結膜炎の治療薬AK002を開発する。本社所在地はカリフォルニア州サン・カルロス。   Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood City, CA.
本社所在地 75 Shoreway Road Suite A San Carlos CA 94070 USA
代表者氏名 Christopher Bebbington Christopher Bebbington
代表者役職名 President Founder Director
電話番号 +1 650-597-5002
設立年月日 40969
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.allakos.com
nasdaq_url https://www.nasdaq.com/symbol/allk
adr_tso
EBITDA EBITDA(百万ドル) -30.66500
終値(lastsale) 32.035
時価総額(marketcap) 1349091845.065
時価総額 時価総額(百万ドル) 1485.749
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 1564.622
当期純利益 当期純利益(百万ドル) -31.66600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Allakos Inc revenues was not reported. Net loss increased 83% to $17.9M. Higher net loss reflects Research and Development - Balancing increase of 64% to $13.2M (expense) General and Administrative - Balancing increase from $1.4M to $4M (expense) Stock-based Compensation in SGA increase from $86K to $718K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.24 to -$0.43.

 ALLKのテクニカル分析


 ALLKのニュース

   Why Allakos (ALLK) Stock Might be a Great Pick  2020/05/15 13:02:00 Zacks Investment Research
Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy  2020/05/14 16:00:06 Zacks Investment Research
Allakos Inc (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
   ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm – ALLK  2020/05/11 14:03:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the “Class Period”) of the important May 11, 2020 lead plaintiff deadline in the securities class action commenced by the firm. The lawsuit seeks to recover damages for Allakos investors under the federal securities laws. To join the Allakos class action, go to http://www.rosenlegal.com/case
   ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.  2020/05/06 14:12:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Californi
   MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/05/06 13:47:21 NewMediaWire
Los Angeles, CA - (NewMediaWire) - May 6, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. (“Allakos” or “the Company”) (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Why Allakos (ALLK) Stock Might be a Great Pick  2020/05/15 13:02:00 Zacks Investment Research
Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy  2020/05/14 16:00:06 Zacks Investment Research
Allakos Inc (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
   ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm – ALLK  2020/05/11 14:03:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the “Class Period”) of the important May 11, 2020 lead plaintiff deadline in the securities class action commenced by the firm. The lawsuit seeks to recover damages for Allakos investors under the federal securities laws. To join the Allakos class action, go to http://www.rosenlegal.com/case
   ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.  2020/05/06 14:12:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Californi
   MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/05/06 13:47:21 NewMediaWire
Los Angeles, CA - (NewMediaWire) - May 6, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. (“Allakos” or “the Company”) (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Why Allakos (ALLK) Stock Might be a Great Pick  2020/05/15 13:02:00 Zacks Investment Research
Allakos (ALLK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
   All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy  2020/05/14 16:00:06 Zacks Investment Research
Allakos Inc (ALLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
   ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm – ALLK  2020/05/11 14:03:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) between August 5, 2019 through December 17, 2019, inclusive (the “Class Period”) of the important May 11, 2020 lead plaintiff deadline in the securities class action commenced by the firm. The lawsuit seeks to recover damages for Allakos investors under the federal securities laws. To join the Allakos class action, go to http://www.rosenlegal.com/case
   ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.  2020/05/06 14:12:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK) between August 5, 2019 and December 17, 2019 (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Californi
   MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/05/06 13:47:21 NewMediaWire
Los Angeles, CA - (NewMediaWire) - May 6, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. (“Allakos” or “the Company”) (NASDAQ: ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.

 関連キーワード  (医薬品 米国株 アラコス ALLK Allakos Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)